UPDATE: Sterne Agee Initiates Coverage On Molina Healthcare As Mean Reversion Is Underway

In a report published Friday, Sterne Agee analyst Brian Wright initiated coverage on Molina Healthcare MOH with a Buy rating and $69.00 price target. In the report, Sterne Agee noted, “We believe MOH shares do not fully reflect normalized earnings power and investors receive post '15 top-line growth for free. Molina shares are currently valued at just 7.0x a 2% net margin derived EPS based on '15 premiums. "We believe the discount is a function of two factors: 1) concern about Sovaldi and other high-cost specialty pharmaceuticals treating Hepatitis-C coming to market late in '14 and 2) anchoring to recent trough net margin levels with investors less willing to contemplate cash earnings guidance. On a cash earnings basis, MOH shares are currently valued at just 12.0x '14 guidance (including $0.48 per share in stock-based compensation).” Molina Healthcare closed on Thursday at $44.53.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorInitiationAnalyst RatingsBrian WrightSterne Agee
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!